Loading clinical trials...
Loading clinical trials...
An Open Label Randomized Clinical Trial, to Evaluate the Treatment With Darunavir/Ritonavir + Lamivudine Once Daily Versus Continuing With Darunavir/Ritonavir Once Daily + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject With Suppressed Plasma Viremia
Conditions
Interventions
Darunavir/Ritonavir
Lamivudine
+1 more
Locations
21
Spain
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
Hospital General Universitario de Alicante
Alicante, Spain
Hospital Universitario Germans Trias i Pujol
Badalona, Spain
Hospital Clinic
Barcelona, Spain
Hospital de La Santa Creu I Sant Pau
Barcelona, Spain
Hospital del Mar
Barcelona, Spain
Start Date
July 1, 2014
Primary Completion Date
April 1, 2016
Completion Date
April 1, 2016
Last Updated
February 14, 2017
NCT04929028
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
Fundacion SEIMC-GESIDA
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions